We use cookies to personalise the web experience for you. By using www.helgilibrary.com, you agree to our use of cookies.
Some cookies are also used by Google Analytics, which anonymously tracks visitors and helps us to analyse how users use our website. Read more

Biocel Paskov

Paper, Pulp & Forestry > Czech Republic > Biocel Paskov
Change Company
Biocel Paskov
Biocel Paskov a.s. is a Czech Republic-based manufacturer of viscose pulp for the textile industry in Austria, the Netherlands, Estonia, and internationally. The Company was founded in 2001 and is based in Paskov, Czech Republic. Biocel Paskov a.s. operates as a subsidiary of Lenzing Aktiengesellschaft.

Buy all financials of Biocel Paskov

from $199 /month

Buy annual subscriptions for all our products.

summary Unit
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

income statement

Sales CZK mil
Gross Profit CZK mil
EBIT CZK mil
Net Profit CZK mil
ROE %
EBIT Margin %
Net Margin %
Employees
...     3,119 4,095 3,914 3,778 4,330    
...     538 1,018 306 386 583    
...     52.9 590 -107 -30.3 163    
...     -19.0 467 -83.6 -99.0 -39.1    
...     -0.590% 16.0% -3.06% -3.79% -1.51%    
...     1.70% 14.4% -2.73% -0.803% 3.76%    
...     -0.609% 11.4% -2.13% -2.62% -0.904%    
      379 374 387 396 398    

balance sheet

...     4,451 4,014 4,454 5,563 6,500    
...     2,363 2,290 2,913 4,135 5,113    
...     2,085 1,723 1,530 1,421 1,386    
...     3,028 2,821 2,643 2,577 2,597    
...     1,423 1,193 1,811 2,986 3,903    
...     150 419 104 299 200    
...     634 726 1,630 934 2,010    
...     -0.334 -0.180 3.49 7.35 5.41    
...     -0.042 -0.057 0.244 0.666 1.06    
... ...   14.7% 3.05% -2.19% 6.75% 8.87%    

Download Data
income statement Unit
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

income statement

Sales CZK mil
Cost of Goods & Services CZK mil
Gross Profit CZK mil
Staff Cost CZK mil
Other Cost CZK mil
EBITDA CZK mil
Depreciation CZK mil
EBIT CZK mil
Financing Cost CZK mil
Extraordinary Cost CZK mil
Pre-Tax Profit CZK mil
Tax CZK mil
Minorities CZK mil
Net Profit CZK mil
...     3,119 4,095 3,914 3,778 4,330    
...     2,580 3,076 3,608 3,392 3,747    
...     538 1,018 306 386 583    
...     204 230 220 329 231    
...     -49.3 -102 -99.1 -177 -155    
...     383 891 185 234 507    
...     330 300 292 264 344    
...     52.9 590 -107 -30.3 163    
...     83.4 13.3 -13.1 95.1 209    
...     0.000 0.000 0.000 0.000 0.000    
...     -30.5 577 -93.7 -125 -46.0    
...     -11.5 110 -10.1 -26.4 -6.89    
...     0.000 0.000 0.000 0.000 0.000    
...     -19.0 467 -83.6 -99.0 -39.1    

growth rates

... ...   -10.5% 31.3% -4.41% -3.48% 14.6%    
... ...   5.83% -17.5% -5.49% 25.8% -50.0%    
... ...   -34.7% 132% -79.2% 26.3% 117%    
... ...   -77.9% 1,015% -118% -71.6% -637%    
... ...   -105% -1,993% -116% 33.9% -63.3%    
... ...   -104% -2,557% -118% 18.4% -60.5%    

ratios

...     -0.590% 16.0% -3.06% -3.79% -1.51%    
... ...   -0.641% 16.6% -2.57% -2.43% -0.777%    
...     17.3% 24.9% 7.81% 10.2% 13.5%    
...     12.3% 21.7% 4.72% 6.18% 11.7%    
...     1.70% 14.4% -2.73% -0.803% 3.76%    
...     -0.609% 11.4% -2.13% -2.62% -0.904%    
... ...   14.7% 3.05% -2.19% 6.75% 8.87%    
...     -0.334 -0.180 3.49 7.35 5.41    

Download Data
balance sheet Unit
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

balance sheet

...     2,363 2,290 2,913 4,135 5,113    
...     2,322 2,276 2,677 4,111 5,099    
...     39.6 12.3 35.2 22.7 12.4    
...     2,085 1,723 1,530 1,421 1,386    
...     352 507 599 699 649    
...     538 699 540 399 428    
...     718 444 270 183 70.5    
...     4,451 4,014 4,454 5,563 6,500    
...     3,028 2,821 2,643 2,577 2,597    
...     0.000 0.000 0.000 0.000 0.000    
...     1,423 1,193 1,811 2,986 3,903    
...     150 419 104 299 200    
...     508 281 0.000 1,647 1,366    
...     150 138 104 110 93.1    
...     634 726 1,630 934 2,010    
...     81.1 3.36 916 254 1,445    
...     559 562 473 666 677    
...     48.2 48.1 77.3 93.1 102    
...     4,451 4,014 4,454 5,563 6,500    

growth rates

... ...   -5.75% -9.81% 11.0% 24.9% 16.8%    
... ...   -11.1% -6.85% -6.32% -2.50% 0.775%    
... ...   -195% 24.9% -504% 166% 59.6%    
... ...   8.89% -51.8% 222% 108% 47.9%    

ratios

...     590 284 916 1,901 2,811    
...     -128 -160 646 1,717 2,741    
...     330 645 665 432 399    
...     2,693 2,934 3,578 4,566 5,512    
...     -0.042 -0.057 0.244 0.666 1.06    
... ...   14.7% 3.05% -2.19% 6.75% 8.87%    

Download Data
cash flow Unit
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

cash flow

Net Profit CZK mil
Depreciation CZK mil
...     -19.0 467 -83.6 -99.0 -39.1    
...     330 300 292 264 344    

ratios

...     62.9 62.3 50.3 38.6 36.1    
...     49.7 60.1 60.6 75.2 63.2    
...     79.1 66.6 47.9 71.7 66.0    
...     33.6 55.8 63.0 42.1 33.3    
...     311 767 208 165 305    

Download Data
other data Unit
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

other data

...     -0.414% 11.0% -1.97% -1.98% -0.649%    
...     17.3% 24.9% 7.81% 10.2% 13.5%    
      379 374 387 396 398    
...     2,358 2,683 2,679 3,545 2,474    
...     44,946 51,281 47,381 69,337 48,408    
...     6.67% 6.57% 5.47% 8.65% 5.55%    
...     37.7% 19.1% 10.8% 21.1% 15.0%    
      2,846 3,616 3,383 3,392 4,160    
      1,167 1,599 2,011 1,684 1,928    

Download Data

Biocel Paskov's net debt reached CZK 1,368 mil and accounted for 0.331 of equity at the end of 2015. The ratio is down 58% when compared to the previous year.

Historically, the firm’s net debt to equity reached an all time high

Read more »

Biocel Paskov's net debt reached CZK 1,368 mil and accounted for 0.331 of equity at the end of 2015. The ratio is down 58% when compared to the previous year.

Historically, the firm’s net debt to equity reached an all time high of 1.06 in 2013 and an all time low of -0.057 in 2010.

When compared to EBITDA, net debt amounted to 0.693x at the end of the year. The ratio reached an all time high of 7.35 in 2012 and an all time low of -0.334 in 2009.

As far as Biocel Paskov's peers are concerned, Lesy Ceske republiky posted net debt to equity of -0.098x and -0.945x when compared to EBITDA at the end of 2015. Stora Enso Wood Products Zdirec ended the year 2015 with a net debt at 0.595x of equity and 1.37x when compared to its EBITDA while Stora Enso Wood Products Zdirec had net debt at 0.595x of equity and 1.37x to EBITDA at the end of the year.

You can see all the company’s data at Biocel Paskov Profile, or you can download a report on the company in the report section.

Biocel Paskov's total assets reached CZK 7,082 mil at the end of 2015, up 8.14% when compared to the previous year.

Current assets amounted to CZK 2,539 mil, or 35.9% of total assets while cash reached CZK 767 mil at the end of 2015.

Read more »

Biocel Paskov's total assets reached CZK 7,082 mil at the end of 2015, up 8.14% when compared to the previous year.

Current assets amounted to CZK 2,539 mil, or 35.9% of total assets while cash reached CZK 767 mil at the end of 2015.

On the other hand, total debt reached CZK 2,135 mil at the year-end, or 35.9% of total assets while firm's equity amounted to CZK 4,130 mil. As a result, net debt reached CZK 1,368 mil at the end of 2015 and accounted for 33.1% of equity.

You can see all the company’s data at Biocel Paskov Profile, or you can download a report on the company in the report section.

Biocel Paskov made a net profit of CZK CZK 996 mil under revenues of CZK 5,618 mil in 2015, up 73.1% and 6.82%, respectively, when compared to the last year.

This translates into a net margin of 17.7%. Historically, the firm’s

Read more »

Biocel Paskov made a net profit of CZK CZK 996 mil under revenues of CZK 5,618 mil in 2015, up 73.1% and 6.82%, respectively, when compared to the last year.

This translates into a net margin of 17.7%. Historically, the firm’s net margin reached an all time high of 17.7% in 2015 and an all time low of -2.62% in 2012. The average net margin in the last five years amounted to 4.60%.

On the operating level, EBITDA margin reached 26.9% and EBIT amounted to 35.2% of sales in 2015.

As far as Biocel Paskov's peers are concerned, Lesy Ceske republiky posted net and EBITDA margin of 45.5% and 59.2%, respectively in 2015 and Stora Enso Wood Products Zdirec generated margins of 5.83% and 5.56%.

You can see all the company’s data at Biocel Paskov Profile, or you can download a report on the company in the report section.

Biocel Paskov made a net profit of CZK 996 mil in 2015, up 73.1% when compared to the previous year. Historically, company's net profit reached an all time high of CZK 996 mil in 2015 and an all time low of CZK -99.0 mil in 2012.

Read more »

Biocel Paskov made a net profit of CZK 996 mil in 2015, up 73.1% when compared to the previous year. Historically, company's net profit reached an all time high of CZK 996 mil in 2015 and an all time low of CZK -99.0 mil in 2012.

This implies return on equity of 28.1% and return on invested capital of 26.5% in 2015. That is compared to 8.08% and 6.19% average seen in the last five years.

Since 2010, net profit of the firm increased by 60.1% or 9.87% a year on average.

As far as Biocel Paskov's peers are concerned, Lesy Ceske republiky generated ROE of 7.66% and ROCE of 8.44% in 2015 Stora Enso Wood Products Zdirec 's profitability reached 39.4% and 24.5%, respectively..

You can see all the company’s data at Biocel Paskov Profile, or you can download a report on the company in the report section.

See all charts of the company »
Biocel's net profit rose 73.1% to CZK 996 mil in 2015
Biocel's employees fell 3.91% to 369 in 2015
Biocel's Cash & Cash Equivalents rose 78.0% to CZK 767 mil in 2015
Biocel's ROCE rose 161% to 26.5% in 2015
Biocel's Net Margin rose 62.1% to 17.7% in 2015
Biocel's Net Debt/EBITDA fell 58.0% to 0.693 in 2015